Jude Samulski

Founder of the University of North Carolina Gene Therapy Center

Bamboo Therapeutics and Asklepios BioTherapeutics

Dr R. Jude Samulski is a Professor of Pharmacology and the Director of the Gene Therapy Center at UNC. Over 25 years, he has led a team of multiple Principal Investigators developing novel viral vectors and clinical gene therapy programs. In addition to being the lead inventor on over 300 patents in the field of Adeno-associated virus (AAV) vectors & gene therapy, he is a scientific founder of AGCT, Merlin, Asklepios Biopharmaceutical, NanoCor Therapeutics, Chatham Therapeutics, Bamboo Therapeutics, Viragen, and other entities that continue to advance the field of human gene therapy. He served as Vice President of Gene Therapy in Pfizer’s Rare Disease Research Unit until February 2018, when he returned full-time to his professorship at UNC. He is a former member of the Recombinant DNA Advisory Committee (RAC), and frequently serves as a gene therapy consultant to the FDA. He received his PhD in Medical Microbiology and Immunology from the University of Florida.